These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 30995348)

  • 1. The zinc finger protein GATA4 induces mesenchymal-to-epithelial transition and cellular senescence through the nuclear factor-κB pathway in hepatocellular carcinoma.
    Xiang Q; Zhou D; He X; Fan J; Tang J; Qiu Z; Zhang Y; Qiu J; Xu Y; Lai G
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2196-2205. PubMed ID: 30995348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells.
    Hu B; Ding GY; Fu PY; Zhu XD; Ji Y; Shi GM; Shen YH; Cai JB; Yang Z; Zhou J; Fan J; Sun HC; Kuang M; Huang C
    J Hematol Oncol; 2018 Feb; 11(1):28. PubMed ID: 29482578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma.
    Chen R; Cheng Q; Owusu-Ansah KG; Song G; Jiang D; Zhou L; Xu X; Wu J; Zheng S
    Int J Biol Sci; 2020; 16(3):495-503. PubMed ID: 32015685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
    J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
    Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
    Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CIP2A attenuates tumor progression by inducing cell cycle arrest and promoting cellular senescence in hepatocellular carcinoma.
    Yang X; Qu K; Tao J; Yin G; Han S; Liu Q; Sun H
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1807-1814. PubMed ID: 29175329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
    Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
    Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX18 Affects Cell Viability, Migration, Invasiveness, and Apoptosis in Hepatocellular Carcinoma (HCC) Cells by Participating in Epithelial-to-Mesenchymal Transition (EMT) Progression and Adenosine Monophosphate Activated Protein Kinase (AMPK)/Mammalian Target of Rapamycin (mTOR).
    Sun Y; Lei B; Huang Q
    Med Sci Monit; 2019 Aug; 25():6244-6254. PubMed ID: 31427562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tumor suppressor enhancing module orchestrated by GATA4 denotes a therapeutic opportunity for GATA4 deficient HCC patients.
    Lu F; Zhou Q; Liu L; Zeng G; Ci W; Liu W; Zhang G; Zhang Z; Wang P; Zhang A; Gao Y; Yu L; He Q; Chen L
    Theranostics; 2020; 10(2):484-497. PubMed ID: 31903133
    [No Abstract]   [Full Text] [Related]  

  • 12. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Over-Expression of Zinc-Finger Protein (ZFX) on Self-Renewal and Drug-Resistance of Hepatocellular Carcinoma.
    Zhang S; Shu R; Yue M; Zhang S
    Med Sci Monit; 2016 Aug; 22():3025-34. PubMed ID: 27566731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH
    Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. circLARP4 induces cellular senescence through regulating miR-761/RUNX3/p53/p21 signaling in hepatocellular carcinoma.
    Chen Z; Zuo X; Pu L; Zhang Y; Han G; Zhang L; Wu J; Wang X
    Cancer Sci; 2019 Feb; 110(2):568-581. PubMed ID: 30520539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
    Song FN; Duan M; Liu LZ; Wang ZC; Shi JY; Yang LX; Zhou J; Fan J; Gao Q; Wang XY
    PLoS One; 2014; 9(9):e108507. PubMed ID: 25268581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-16 inhibits hepatocellular carcinoma progression by targeting FEAT through NF-κB signaling pathway.
    Su XF; Li N; Meng FL; Chu YL; Li T; Gao XZ
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10274-10282. PubMed ID: 31841182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
    Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
    DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.